Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT05649891 Not yet recruiting - Pneumonia Clinical Trials

Checklists Resuscitation Emergency Department

Start date: September 2023
Phase: N/A
Study type: Interventional

The study will systematically evaluate how an emergency manual-a collection of checklists and fact sheets-affects the performance of resuscitation teams during the management of priority one patients in an emergency department.

NCT ID: NCT05645887 Not yet recruiting - Septic Shock Clinical Trials

Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

ALBUMIM
Start date: November 2023
Phase: Phase 2
Study type: Interventional

The goal of this phase 2, multicenter, randomized, controlled study is to evaluate the effect of albumin treatment on B cell and other immune cell gene exptression in adults with septic shock.

NCT ID: NCT05586282 Not yet recruiting - Septic Shock Clinical Trials

Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure

Start date: November 2022
Phase:
Study type: Observational

- Testing the association between circulating candidate proteins and the level of vascular leakage for three distinct forms of circulatory failure: cardiogenic shock, septic shock, and post-resuscitation syndrome. - Describing immuno-inflammatory profiles associated with massive vascular leakage during those three forms of circulatory failure in humans

NCT ID: NCT05572060 Not yet recruiting - Septic Shock Clinical Trials

Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

We aimed to determine if metformin use in both diabetic and non diabetic patients with sepsis and septic shock affects 28 day mortality and its effect on inflammatory markers. Plasma rennin, serum lactate concentration and IL6 will be measured for predicting 28 days in-hospital mortality in patients with sepsis.

NCT ID: NCT05551910 Not yet recruiting - Clinical trials for Patients With Septic Shock Admitted to the ICU on Invasive Mechanical Ventilation

Comparison of Analgesic and Sedative Effects of Esmketamine and Remifentanil Combined With Propofol Respectively in Septic Shock Patients With Invasive Mechanical Ventilation

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Septic shock patients with invasive mechanical ventilation who were randomly enrolled in ICU were divided into esketamine group (test group) and remifentanil group (control group) according to the ratio of 1:1. The dose of vasopressor, the time of mechanical ventilation, the incidence of intestinal dysfunction and the dose of propofol were compared between the two groups. Through statistical analysis, it was determined whether esketamine combined with propofol could improve the prognosis of septic shock patients with invasive mechanical ventilation and reduce the adverse reactions of analgesic and sedative drugs compared with remifentanil combined with propofol.

NCT ID: NCT05463471 Not yet recruiting - Shock Clinical Trials

Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients

Start date: August 1, 2022
Phase: Phase 4
Study type: Interventional

To compare the direct effect of sodium acetate ringer injection or albumin on volume expansion in shock patients, and to provide reference for volume resuscitation strategy in shock patients

NCT ID: NCT05444621 Not yet recruiting - Septic Shock Clinical Trials

Carotid Ultrasounds Measurements in Septic Shock

Start date: July 1, 2022
Phase:
Study type: Observational

The aim of the study is to assess carotid ultrasounds measurements, namely corrected flow time (FTc), velocity time integral (VTI) and respirophasic variation in carotid artery blood flow peak velocity (ΔVpeak), as a predictor of fluid responsiveness in septic shock patients.

NCT ID: NCT05404165 Not yet recruiting - Clinical trials for Severe Anaphylactic Reaction, Self-administration, Adrenaline, Self-assessment

Relevance of the Self-assessment of Skills for Self-administration of Adrenaline by Auto-injectors in Patients at Risk of Severe Anaphylactic Reaction (PacAdré)

PacAdré
Start date: May 23, 2022
Phase:
Study type: Observational

To investigate the correlation between self-assessment by patients and an assessment by a health professional of the skills needed for self administration of adrenaline by auto-injectors. These skills include the identification of situations requiring the administration of adrenaline and the technical abilities to achieve it. Hypothesis: A self-assessment correlated with an external assessment would make it easier to adjust the frequency of therapeutic education sessions based on the patient's self-assessment alone.

NCT ID: NCT05389176 Not yet recruiting - Septic Shock Clinical Trials

Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

A sigle-center, randomized controlled trial will be do to investigate the effects of esomol on heart rate, clinical parameters, mortality, and safety in septic shock patients with tachycardia at different stages, compared with patients who received conventional therapy.

NCT ID: NCT05327881 Not yet recruiting - Septic Shock Clinical Trials

Serum Rennin Kinetics Versus Serum Lactate Kinetics as Predictors of Mortality in Septic Shock Patients

Start date: June 30, 2022
Phase:
Study type: Observational

Whole blood lactate concentration is widely used in shock states to assess perfusion. We aimed to determine if the change in plasma renin concentration over time would be superior to the change in lactate concentration for predicting in-hospital mortality in septic shock patients.